Prostatic hyperplasia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria of BPH; 2. Conform to the syndrome differentiation standard of kidney deficiency, blood stasis and dampness syndrome (not required by Western Hospital); 3. Men aged 50-80 years; 4. Sign the informed consent voluntarily.
Exclusion criteria
Exclusion criteria: 1. Residual urine volume > 150ml; 2. There are other diseases that cause dysuria, such as neurogenic bladder dysfunction, vesicourethral calculus, bladder neck obstruction, urethral stricture, recurrent urinary infection, urinary incontinence, pelvic radiotherapy, postoperative pelvic surgery, bacterial prostatitis, and patients or blood PSA >4 whose prostate biopsy shows any grade of prostatic intraepithelial tumor (PIN) Ng / ml patients with suspected prostate cancer; 3. Received soft / hard cystoscopy or other urethral instrument operators within 7 days before the study; 4. Patients with gastroduodenal ulcer, acute and chronic gastritis and enteritis; 5. Those who have recently complicated with serious cardiovascular and cerebrovascular diseases, serious liver and kidney damage, severe hypertension, poor control of diabetes, blood system diseases, mental disorders, and a history of alcohol dependence or drug abuse; 6. Those who are allergic to the ingredients in the study drug; 7. According to the judgment of the researcher, it is not suitable to join the clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| International Prostate Symptom (I-PSS) score;Curative effect of TCM Syndrome; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life index (QOL) score;Residual urine volume of bladder (PVR);Prostate volume;Efficacy of single symptom; | — |
Countries
China